Gaurav Garg, Head of Research, CapitalVia answers readers' stock market queries.
Ranbaxy board has approved the hive off of its R&D unit, with an 1:4 share swap ratio.
T K has been an integral part of the organisation's leadership for years, says Azim Premji.
Patni Computer Systems Inc, a wholly-owned subsidiary of Patni Computer Systems, on Monday announced the acquisition of Bridgewater, NJ-based Taratec Development Corp for an aggregate price of $27.2 million in cash.
VIGSR, in Mumbai, offers the first postgraduate diploma in medical genetics in India.
RPG Life already has marketing tie-ups with Israel's drug major Teva for the EU market and with the US-based Apotex for the Canadian market.
The west is faced with a daunting task on patent expiry, increasing challenges from generics, pipeline showing limited blockbusters, and in addition to that increasing pricing pressure.
The company's revenue rose 16.08 per cent to Rs 25,668 crore.
BARC invites applications for its PhD programme commencing in September 2008 under the aegis of HBNI.
'At any given point in time, we expect only 25 per cent of our workforce will need to be in office.' 'And any given person will only be required to spend only 25 per cent of their time in office.'
Biovel Life Sciences (P) Ltd, a biotechnology firm, has inked a licensing agreement with US-based Dowpharma to produce Human Growth Hormone using Pfenex Expression Technology, for the first time globally.
Despite news of the private equity in the domestic healthcare and pharma industry touching almost Rs 40 crore (Rs 40 million) in the first nine months of the year, PE firms are not exactly bullish about investing in the pharma industry alone. In fact, a closer look at the investments reveals that a larger part of the money is being flown into healthcare delivery systems like hospital chains and not in pharma companies.
Institute of Bioinformatics and Applied Biotechnology, Bangalore, invites applications for its Post-graduate Diploma in Bioinformatics and Laboratory Course in Biotechniques programmes.
Reliance Pharmaceuticals, the proposed pharmaceutical manufacturing company promoted by Mukesh Ambani's Reliance Life Sciences, will soon rope in a consultant to give final shape to the project, slated to take off within two years.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Competing with established biotech companies in India such as Wockhardt, Biocon and Reliance Life Sciences, small biotech companies such as Zenotech, BV Biocorp and Intas Biopharma are likely to emerge as major players in biogeneric drugs.
The Bharathidasan University and Mediscan Institute of Medical Education, Chennai invite applications for admission to their job-oriented full-time, two year, diploma programmes.
Tata Memorial Hospital, Mumbai, invites applications for its Master's Course in Epidemiology and Clinical Research in Oncology.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Mark Zuckerberg's pledge on Tuesday to give away most of his Facebook shares, a roughly $45 billion fortune, helps cement his role as one of Silicon Valley's most generous donors.
Presenting the Top 20 of 100 science colleges as per India Today's findings.
Presenting the Top 20 of 100 science colleges as per India Today's findings.
Global pharma and biotech companies, especially those from US, Europe and Japan, are keen to sign agreements with Indian companies, according to experts.
Netmed plans to procure from drug manufacturers and sell to pharmacies it has tie-ups with, and to spread its network to all tier-II and tier-III cities.
The Welingkar Institute of Management, India, and Nottingham Trent University, UK, invite applications for their M Sc Bioinformatics programme.
Suven Life Sciences Ltd has signed an agreement with US-based pharmaceutical firm Eli Lilly and Company to carryout pre-clinical research for central nervous system disorder.
Mukesh Ambani-promoted biotech venture Reliance Life Sciences is close to acquiring a US company for nearly $1 billion (Rs 4,500 crore).
The Institute of Clinical Research (India) invites applications for its one-year part-time Professional Certificate Programme in Clinical Research and Trials Management and the Professional Certificate Programme in Regulatory Affairs and Ethics.
Hyderabad is fast emerging as destination for pharma and bio-tech industries with projected growth of 30 to 40 per cent, consultant company Frost and Sullivan has said.
Alert: Post-doctoral fellowships in Biotechnology and Life Sciences
Meet the world's top venture capitalists, the early investors behind some of the biggest IPOs on the planet.
India to see highest salary increase in Asia Pacific in 2017
Mukesh Ambani-controlled Reliance Life Sciences is to invest $63.2 million for a controlling stake in UK's biopharmaceutical company GeneMedix Plc.
Students, professors and women rights organisations have been protesting, demanding his arrest, after some students accused him of sexual harassment.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances